SCHEMBL29454333

SCHEMBL29454333

Cc1cc(N)c(Cl)c(Cc2ccccc2Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.41
CNR2 P34972 1/20 0.41
MPO P05164 1/20 0.40
ADCY10 Q96PN6 1/20 0.40
TAAR1 Q96RJ0 2/20 0.40
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 1/20 0.39
IDO1 P14902 3/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
AOC3 Q16853 1/20 0.38
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29454303 0.88 PNMT (0.42) PNMTCNR2MPOADCY10TAAR1
SCHEMBL22232311 0.88 PNMT (0.42) PNMTCNR2MPOADCY10TAAR1
SCHEMBL22232185 0.87 TAAR1 (0.39) CNR2TAAR1ALDH1A1CYP1A2HSD17B10
SCHEMBL22232231 0.85 TAAR1 (0.39) TAAR1ALDH1A1CYP1A2CYP2C19HSD17B10
SCHEMBL22231804 0.84 MPO (0.45) PNMTMPOTAAR1ALDH1A1IDO1
SCHEMBL22232180 0.84 ADCY10 (0.42) MPOADCY10TAAR1ALDH1A1CYP1A2
SCHEMBL22232349 0.81 CYP3A4 (0.41) ADCY10CYP2C19HSD17B10MEN1KMT2A
SCHEMBL29454241 0.81 CYP3A4 (0.41) ADCY10CYP2C19HSD17B10MEN1KMT2A
SCHEMBL22231996 0.80 IDO1 (0.41) ALDH1A1CYP1A2CYP2C19IDO1MEN1
SCHEMBL22231842 0.80 TSHR (0.36) ALDH1A1CYP1A2CYP2C19HSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545639-B2 3-substituted phenylamidine compounds, preparation and use thereof PI INDUSTRIES LTD. (IN) 2026-02-10 US disclosed
US-20220089523-A1 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS, PREPARATION AND USE THEREOF PI INDUSTRIES LTD. (IN) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089523-A1 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS, PREPARATION AND USE THEREOF H1-3, PRMT7, PFAS PNMT 103/4885CNR2 2634/4885MPO 1451/4885
US-12545639-B2 3-substituted phenylamidine compounds, preparation and use thereof CBR1, CBR3, HCCS PNMT 731/4885CNR2 60/4885MPO 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.